Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $ACB.TO,
CSE: $MTEC.C, CSE: $LIB.C
Delta, Kelowna, BC –August 20, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08201Potcasts-TSX-ACB-CSE-MTEC-LIB.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Aurora Cannabis Inc.
trading on the TSX as ACB and the OTCQB as ACBFF, Cannvas MedTech Inc. trading on the CSE as MTEC and Liberty Leaf Holdings
Ltd. trading on the CSE as LIB and the OTCQB as LIBFF.
Aurora Cannabis Inc. today announced that, in connection with the
spin-out of its subsidiary Australis Capital Inc., Aurora has set Friday August
24, 2018 as the record date for the distribution of Australis units.
Canadian shareholders as at the record date will be eligible to receive
the Distribution. Non-resident shareholders will be entitled to receive a cash
payment net of any applicable withholding taxes following a sale of their
respective units in the open market by an independent custodian following the
Distribution. Consequently, Aurora anticipates the completion of the
Distribution to shareholders and the public listing of Australis on the CSE to
be completed in September 2018.
Cannvas MedTech Inc., a leading business
technology company in the cannabis space, and CanvasRx, a wholly owned
subsidiary of Aurora Cannabis Inc. operating 29 clinics across Canada,
announced the signing of a letter of intent, to negotiate, in good faith, a
patient aggregation agreement after an exploratory period of up to six months
during which Cannvas and CanvasRx agree to mutually create data models through
the Cannvas.me platform suited for CanvasRx's B2B and B2C businesses.
With strong partnerships, a network of clinics, and access to, and
information on hundreds of strains of medical cannabis from the top Licensed
Producers in Canada, CanvasRx has developed a powerhouse of education and
information for the cannabis industry. People use CanvasRx to learn about
medical cannabis, find knowledgeable doctors, select strains and track their
outcomes with Patient Reporting tools developed by physicians.
During the exploratory period, Cannvas will develop specific parameters
within its existing Cannvas Data framework to collect data and analytics from
CanvasRx and their strategic partnerships, and provide CanvasRx with access to
the Cannvas.me dataset. CanvasRx will benefit from using Cannvas.me proprietary
databases and algorithms to gain insights to their existing and future membership
base. The two companies will work together to enhance user experiences across
each respective online platform and explore ways to improve the overall
education of visitors in a non-biased and independent method, including
positioning the Cannvas.me educational platform within the CanvasRx chain of
medical cannabis clinics.
Liberty Leaf Holdings Ltd. announced the completion of
its first CBD research trial on pain medication for dogs.
Liberty Leaf has a Collaborative Agreement with ESEV Research
Development, a leading Israeli-American research and development company, for
them to conduct research into the efficacy of CBD-containing products for
treating specific medical conditions in pets. The project is being
managed and overseen by Pharmaseed, ESEV's partner in Israel.
This is the first study of several to be conducted under the
Collaborative Agreement. The study included large mixed-breed dogs, which
received a proprietary CBD-infused oil formulation or placebo in the active
phase of study. Oral CBD-infused oil provides the most effective means of
delivery of CBD to dogs.
The focus of this first study was on treating dogs with chronic
osteoarthritic pain. Osteoarthritis (OA) is one of the most common diseases in
dogs, characterized by pain, stiffness, lethargy and decreased mobility, which
leads to reduction in their quality of life.
CBD offers a potential solution for both owner and pet. In fact,
dogs should be able to take advantage of the pain management capabilities of
CBD even more so than humans since dogs have a more extensive endocannabinoid
system with which CBD can interact. This interaction helps to reduce pain
and other symptoms linked to the endocannabinoid system.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via Spreaker,
iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
No comments:
Post a Comment